Intervention
Women who underwent forceps or vacuum delivery after gestation periods
of at least 36 weeks were randomised to receive a single prophylactic
dose of IV co-amoxiclav provided there were no contraindications. A
placebo (0.9% saline) was chosen as the comparator in this economic
evaluation as it was in the ANODE trial1. This is
because current WHO recommendations state that no antibiotic prophylaxis
should be provided following operative vaginal
delivery6.